
51 - 200 employees
Founded 2013
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Solid Biosciences is a Charlestown, MA–based precision genetic medicine company focused on developing gene therapies for rare neuromuscular and cardiac diseases. The company advances a portfolio of gene therapy candidates — including SGT-003 for Duchenne muscular dystrophy, SGT-212 for Friedreich’s ataxia, SGT-501 for catecholaminergic polymorphic ventricular tachycardia (CPVT), and SGT-601 for TNNT2-mediated dilated cardiomyopathy — and is developing libraries of genetic regulators and delivery-platform technologies to improve gene therapy delivery. Founded with a patient-focused mission and collaborations across science, technology, and care, Solid emphasizes clinical development, manufacturing infrastructure, and partnerships to bring transformative precision genetic medicines to patients with rare genetic diseases.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 August 13
Technical Quality leader overseeing outsourced gene-therapy manufacturing, testing, packaging, and distribution for Solid Biosciences. Ensuring cGMP compliance, supplier quality, inspections, and regulatory submissions for rare-disease programs.
🕒 July 9
Lead scientific communications and publication strategy at Solid Biosciences, focusing on gene therapy for rare diseases. Collaborate cross-functionally to maximize scientific impact.
🇺🇸 United States – Remote
💵 $270k - $315k / year
⏰ Full Time
🟠 Senior
🗣️ Communications
👻 Ghost score 15%